is PTD-DBM the hair loss miracle peptide nobody is talking about?
it’s a CXXC5 inhibitor that supports β-catenin signaling
- follicle neogenesis
- supports anagen induction/duration
- synergizes w/ other tools
experimental, but could be a gamechanger for hair regrowth
Our findings revealed that CXXC5 plays a key role in AD pathogenesis and suggest inhibition of CXXC5-Dvl interaction as a new therapeutic approach for AD.
https://t.co/zzEdeEDhJJ
#ckregeon #koreanbiotech#safeactivationofwntsignaling #Dementia#Alzheimers Wnt/β-catenin-signaling
Imagine what we can do if we stand together. Meet with us at the 2023 BIO International Convention, June 5-8. Find our company in the partnering system for potential meetings at the largest gathering of the global biotech community!
#ckregeon#koreanbiotech#cxxc5#BIO2023
CK Regeon Inc. is taking the presentation stage at the 2023 BIO International Convention in Boston, June 5-8. We are thrilled to showcase our company's dedication to supporting and empowering the biotech industry as we come together to stand up for science.
#ckregeon#biotech
This is the mechanism of the novel HA-PG adhesive hydrogel patch delivers a combination drug therapy to facilitate regenerative wound healing.
Wound healing and scar reduction of wound therapies can now be achieved by novel regeneration promoting materials. #regenerativewound
We are excited to share that your work, published in British Journal of Pharmacology, is among our most downloaded papers!*
KY19382, a novel activator of Wnt/beta-catenin signalling, promotes hair regrowth and hair follicle neogenesis
#TopDownloadedArticle. #ckregon#bjp
CK Regeon Inc., a company specializing in developing tissue regeneration therapeutics, announced that CK Regeon received a Chinese patent for preventing hair loss or promoting regenerative hair growth. In addition to China, CK Regeon holds patent grants in the U.S., Korea, and EU
CK Regeon Inc., a company specializing in the development of tissue regeneration therapeutics, announced that it obtained a European patent for preventing hair loss or promoting regenerative hair growth. This patent is followed by patent grants in Korea and the United States.
CK Regeon Inc. is participating in person at J.P. Morgan Healthcare Conference 2023! #JPM2023
Please reach out if you have an interesting partnering opportunity in NASH, Alzheimer’s disease, neogenic hair regrowth, and DFU/wound healing.
https://t.co/Zh6mqvdR2q